Emergent Biosolutions Inc (EBS)

CapEx to Revenue

1.53%

TTM · Retrieved:

EBS logo

EBS CapEx to Revenue

Current (TTM)1.53%
EBS CapEx/Revenue (496.59% → 1.53%)
High-resolution chart · PNG

EBS capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Emergent Biosolutions Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
1.8576%
2.1943%
4.9176%
10.3624%
12.6861%
8.9964%
7.8571%
9.2152%
9.775%
15.6009%
9.1578%
7.5836%
13.4362%
19.1016%
19.7619%
7.723%
14.1776%
11.6564%
24.0379%
26.9937%
4.9982%
20.447%
0%
0%
496.5901%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.